The major players in the digital rapid influenza diagnostic test market include Abbott Laboratories, Becton, Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Hologic Inc., Quidel Corp., Siemens Healthineers AG, and Thermo Fisher Scientific Inc.
Influenza viruses being responsible for the winter epidemics of respiratory illness among all age groups will be the primary trending factor for market growth. The increasing demand for RIDTs, especially to detect respiratory outbreaks in any crowded setting to curb the spread rapidly, will expand market growth. The adoption of RIDTs for laboratory-based surveillance for influenza viruses to develop the next season’s influenza vaccine will enhance the market growth. These digital testing platforms eliminating the need for an operator to visualize and interpret test results will be a market booster. These RIDTs with enhanced sensitivity of detection for the seasonal, novel, and variant influenza strains and meeting the FDA’s criteria should expand appropriate patient management opportunities. The possibility of false-positive results is the main hindrance to the growth of the market.
Digital Rapid Influenza Diagnostic Test Market Segmentation
By Product Type
- Machine
- Consumables
By Application
- Hospitals
- POCT
- Others
Source: https://www.valuemarketresearch.com/report/digital-rapid-influenza-diagnostic-test-market
Naira Shekhawat has been into Content Writing just after completing her Graduation in English Literature. Her love for words has won her many accolades in her respective jobs ever since. Naira covers business sections for VMR News. She is a traveller by heart and loves writing on food blogs as a freelancer.